News

Previous literature indicated a higher prevalence of eczema in children who live in areas with hard water, but this association was not explored in adults until now.

Investigator Dr. John Botson spoke on the phase 4 MIRROR study that supported the FDA approval for pegloticase combined with methotrexate for patients with uncontrolled gout.

The overall prevalence of NAFLD was 40.6%, with every NAFLD patient having a BMI of at least 25.

The topical therapy has been under investigation as a first-in-class therapy for this highly contagious skin condition.

A significant factor in treating sickle cell disease is the practice of shared decision-making, which gives the provider and patient a collaborative approach to disease management, according to Dr. Titilope Fasipe.

Buprenorphine has shown to be effective and has the potential for widespread use to address the opioid epidemic. A subset of individuals with OUD have been acquiring it without a prescription.

Dr. Karan Lal provides an overview of laser therapy for acne, and speaks on the "phenomenal" responses observed in patients with the first and only FDA approved laser treatment, AviClear.

Patients with obesity are at an increased risk of a number of diseases, including type 2 diabetes, IBD, and cardiovascular disease.

An Ohio State researcher discusses a new medical center education program for navigating addiction risk in pain patients.

New 21-month data from the SUSTAIN trial found that patients with no history of biologic therapies responded well to secukinumab.

Regular activity impairment did not differ much between the different countries, but there was a significant difference in informal care and productivity loss observed.

Early follow-up in patients with COPD led to lower rates of readmissions at 90 days, while patients with CHF saw lower 90-day mortality.

Dr. John Botson speaks on the new FDA approval of this combination therapy and its strength regarding increased efficacy and safety.

Nearly half of the study cohort did not fill a statin prescription within 90 days after an ASCVD event.

Novartis announces the EC expanded on the approval of secukinumab in EU to include pediatric patients with childhood arthritic conditions: juvenile idiopathic arthritis, enthesitis-related arthritis, and juvenile psoriatic arthritis.

Over a 40-year follow-up, approximately one-quarter of the study cohort with juvenile arthritis were reported to have active uveitis.

Higher energy and longer symptom duration at diagnosis were protective factors against medication failure.

New data suggests that a third COVID-19 booster might be warranted in children with juvenile idiopathic arthritis.

According to preliminary data, patients with JIA experience the same safety and immunogenicity as healthy individuals when vaccinated with the Pfizer COVID-19 vaccine.

Data suggests baricitinib not only significantly reduced the time to flares but also the frequency of flares in patients with JIA when compared with placebo.

A high percentage of pediatric patients with JIA do not achieve inactive disease during the first 2 years following diagnosis.

A new study revealed no significant relationship between patients with juvenile idiopathic arthritis and exposure to maternal infection, however, investigators said that suggestive evidence of differential sex-specific results indicate a need for further study.

Dr. Raina describes the manifestations of pulmonary hypertension, CTEPH, and various treatment options available for the often underlooked condition.

Investigators suggest parents and clinicians should be mindful of children with suspected ACD with a history of exposure to jewelry, clothing, and belts with cobalt.

The majority of cases were mild to moderate in severity.

The Optimal screening ages for two measurements were 2 years and 6 years for the diagnosis of clinical type 1 diabetes.

Investigators suggest confronting sleep difficulties among patients with suicidal ideation through cognitive behavioral intervention could reduce effects of affective reactivity to interpersonal events.

Expert Michael Aziz discusses clinical complications that patients face when they become pregnant as well as the importance of medication management and abortion care.

Nonmetropolitan counties have a lower density of ophthalmologists compared to metropolitan counties.

The results are consistent with the original analysis from 2019, where the treatment resulted in a statistically significant effect on fibrosis improvement.